Chronic cystoid macular oedema treated with intravitreal dobesilate
- 1Department of Research, Hospital Ramon y Cajal, Madrid, Spain
- 2Department of Ophthalmology, Hospital de Día Pio XII, Madrid, Spain
- 3Department of Qiimica de Proteinas, Centro de Investigaciones Biológicas, Madrid, Spain
- Correspondence to Professor Pedro Cuevas,
Competing interests None.
Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.
Patient consent Obtained.